86 research outputs found

    Age-related changes in upper body contribution to braking forward locomotion in women

    Get PDF
    Introduction Gait termination is a transitory task that requires the lower body to produce braking forces and inhibit forward propulsion. However, it is still unknown whether the upper body plays an active role in braking of gait and whether this mechanism is impaired with ageing. Research question Do older women exhibit an impaired control of upper body segments during gait termination with respect to young women? Methods Ten young and 10 older women performed three gait termination trials at comfortable speed while fixing the gaze on a visual target. A 3D motion analysis system was used to measure head, trunk and pelvis angular displacement and velocity, and estimate neck, waist and hip moments through Plug-in Gait modeling. Cross-correlation analysis of kinematic waveforms between paired adjacent segments (head-trunk and trunk-pelvis) was performed to investigate upper body coordination. Surface EMG activity of erector spinae (L3), sternocleidomastoid and neck extensor muscles was recorded. Statistics was carried out by MANOVA. Results Older participants exhibited delayed peak extensor torques of neck, waist and hip compared to young participants, along with lower progression speed. Both groups showed a slight flexion of the trunk counteracted by a backward tilt of head and pelvis during braking. In addition, older women displayed a peculiar upper body coordination pattern, with the head coupling with trunk motion, as shown by cross-correlation. Older women displayed shorter lumbar erector spinae onset latency relative to last heel contact than young (16 ± 68 ms vs 92 ± 37 ms). Significance The upper body plays an active role in the braking of gait and this mechanism is impaired in older women. Moreover, the age-related coupling of head and trunk motion may produce an unbalancing effect on whole-body stability during the braking mechanism, thus leading to a higher risk of falls

    Co-localization of PTEN and E-cadherin in canine mammary hyperplasias and benign and malignant mammary tumours

    Get PDF
    Fifty-four canine mammary lesions (15 hyperplasias, 7 adenomas and 32 carcinomas) were submitted to immunohistochemical analysis for the evaluation of PTEN and E-cadherin co-expression. Subjects bearing mammary carcinomas were also submitted to a 2-year follow-up study to compare immunohistochemical results with overall survival All the hyperplastic samples stained positive for both markers, 100% of adenomas were positive for PTEN and 86% for E-cadherin, and 69% and 34% of carcinomas were positive for PTEN and E-cadherin, respectively. Statistical analysis showed a positive correlation between these two proteins both considering all (p <0.01) or malignant tumours (p <0.05). The female dogs bearing tumours positively-stained for both markers had a longer overall survival (p <0.05) and absence of lymphatics invasion (p <0.05). Simultaneous double immunofluorescence confirmed the co-localization of the two proteins in neoplastic cells. Results reported in this study confirm the tumor suppressor effect of these two molecules

    Tunable mechanical properties of gellan gum/poly (ethylene glycol) diacrylate hydrogels for articular cartilage engineering

    Get PDF
    Articular cartilage (AC) is a complex multi-layered structure organized into four zones, namely superficial, middle, deep and calcified layers [1]. Its mechanical properties are varying with depth, and the compression modulus of the superficial and middle zone can achieve the value of 0.28 ± 0.16 MPa and 0.73 ± 0.26 MPa, respectively [2]. This paper reports the preliminary results concerning mechanically tunable gellan gum/poly (ethylene glycol) diacrylate hydrogels for mimicking the compression mechanical properties of the first two layers of the AC tissue

    Intravitreal infliximab clearance in a rabbit model: different sampling methods and assay techniques.

    Get PDF
    PURPOSE. To investigate the clearance of intravitreal infliximab with the use of different sampling techniques and immunoassay methods in rabbits. METHODS. Infliximab (1.6 mg) was intravitreally injected into both eyes of 47 rabbits. Two approaches were used to collect the vitreous: the classic method and a microsampling technique. Whereas the classic method consists of collection of the whole vitreous after enucleation, the microsampling technique consisted of the aspiration of small (10‐15 L) samples with a 200-L syringe. Samples were taken from 30 minutes to 40 days using both methods and were then compared. Infliximab concentration was estimated with competitive ELISA, dot blot analysis, and Western blot analysis. RESULTS. The vitreous half-life of infliximab was estimated to be 6.5 0.6 days. The data indicated monoexponential decay reaching its conclusion after approximately 40 days. This decay was preceded by 4-day-long diffusion in the vitreous. Microsampling proved to be effective in the vitreous collection, giving statistically comparable signals ( 4%, P 0.68) with respect to the classic procedure. ELISA proved to be the best analytical technique—especially if coupled with microsamplings—because of its lower detection limit, precision, and reduced amount of sample needed. No differences were observed between half-life values obtained by ELISA and dot blot analysis (P 0.081) and Western blot analysis (P 0.614). CONCLUSIONS. The findings of this study added to the knowledge of infliximab clearance in the vitreous and confirmed the validity of a microsampling technique that was compared with the classic one. ELISA was found to be the best analytical technique when using microsampling. (Invest Ophthalmol Vis Sci. 2009;50:5328‐5335) DOI:10.1167/iovs.09-356

    Wear behavior characterization of hydrogels constructs for cartilage tissue replacement

    Get PDF
    This paper aims to characterize the wear behavior of hydrogel constructs designed for human articular cartilage replacement. To this purpose, poly (ethylene glycol) diacrylate (PEGDA) 10% w/v and gellan gum (GG) 1.5% w/v were used to reproduce the superior (SUP) cartilage layer and PEGDA 15% w/v and GG 1.5% w/v were used to reproduce the deep (DEEP) cartilage layer, with or without graphene oxide (GO). These materials (SUP and DEEP) were analyzed alone and in combination to mimic the zonal architecture of human articular cartilage. The developed constructs were tested using a four-station displacement control knee joint simulator under bovine calf serum. Roughness and micro-computer tomography (µ-CT) measurements evidenced that the hydrogels with 10% w/v of PEGDA showed a worse behavior both in terms of roughness increase and loss of uniformly distributed density than 15% w/v of PEGDA. The simultaneous presence of GO and 15% w/v PEGDA contributed to keeping the hydrogel construct’s characteristics. The Raman spectra of the control samples showed the presence of unreacted C=C bonds in all the hydrogels. The degree of crosslinking increased along the series SUP < DEEP + SUP < DEEP without GO. The Raman spectra of the tested hydrogels showed the loss of diacrylate groups in all the samples, due to the washout of unreacted PEGDA in bovine calf serum aqueous environment. The loss decreased along the series SUP > DEEP + SUP > DEEP, further confirming that the degree of photo-crosslinking of the starting materials plays a key role in determining their wear behavior. µ-CT and Raman spectroscopy proved to be suitable techniques to characterize the structure and composition of hydrogels

    Piezoelectric Nanomaterials Activated by Ultrasound: The Pathway from Discovery to Future Clinical Adoption

    Get PDF
    Electrical stimulation has shown great promise in biomedical applications, such as regenerative medicine, neuromodulation, and cancer treatment. Yet, the use of electrical end effectors such as electrodes requires connectors and batteries, which dramatically hamper the translation of electrical stimulation technologies in several scenarios. Piezoelectric nanomaterials can overcome the limitations of current electrical stimulation procedures as they can be wirelessly activated by external energy sources such as ultrasound. Wireless electrical stimulation mediated by piezoelectric nanoarchitectures constitutes an innovative paradigm enabling the induction of electrical cues within the body in a localized, wireless, and minimally invasive fashion. In this review, we highlight the fundamental mechanisms of acoustically mediated piezoelectric stimulation and its applications in the biomedical area. Yet, the adoption of this technology in a clinical practice is in its infancy, as several open issues, such as piezoelectric properties measurement, control of the ultrasound dose in vitro, modeling and measurement of the piezo effects, knowledge on the triggered bioeffects, therapy targeting, biocompatibility studies, and control of the ultrasound dose delivered in vivo, must be addressed. This article explores the current open challenges in piezoelectric stimulation and proposes strategies that may guide future research efforts in this field toward the translation of this technology to the clinical scene
    corecore